DONATE

IBEC promotes dialogue on the translation of personalised medicine into society at Barcelona Health Innovation Week

Today, 19 February, IBEC organised the roundtable ‘Personalised medicine in action: from the lab to society’, an event that formed part of the Barcelona Health Innovation Week, promoted by Biocat. The session provided an insight into the keys to success in translating personalised medicine, connecting with actors in the innovation ecosystem and taking part in the conversation about the future of our health.

IBEC co-funds new state-of-the-art electron microscope

The President of the Catalan Government, Salvador Illa, and the Catalan Minister for Research and Universities, Núria Montserrat, inaugurated this unique infrastructure at the Barcelona Science Park today. The microscope, funded by IBEC and FEDER*, opens the door to the reconstruction of biomolecules and viruses in three dimensions, among other applications.

INTROPY: A new approach to cancer therapy by inhibiting mechanotransduction

IBEC senior researcher Pere Roca-Cusachs has been awarded an ERC Proof of Concept Grant. This is a prestigious grant awarded by the European Research Council to explore the commercial and societal potential of research projects carried out at European institutions. Roca-Cusachs’ project, INTROPY, focuses on the inhibition of mechanotransduction as a potential therapy against cancer or fibrosis.

IBEC teams up with CCCB for ‘Radical Science’ cultural project on 21st century science

IBEC is one of four Catalan research centres collaborating with the Centre de Cultura Contemporània de Barcelona (CCCB) on the ‘Radical Science’ project. This cultural project, which will be launched on 20 January 2025, aims to explore how scientific research is changing the world today. Renowned researchers and artists invite us to reflect on scientific advances in biotechnology, quantum physics and the exploration of the universe.

LUMIRIS, the IBEC spin-off that has raised €6 million to transform assisted reproduction

This spin-off from the Institute for Bioengineering of Catalonia has developed a non-invasive technology that analyses the metabolism of human embryos to select the most suitable ones for implantation. This innovation promises to significantly reduce the time and number of treatment cycles required for in vitro fertilisation. The success of LUMIRIS’ technology has led to a new round of investment of €1.5 million, bringing the total to €6 million since the company was founded in 2023.

IBEC and SJD Barcelona Children’s Hospital strengthen their collaboration with a day of translational innovation

The Institute for Bioengineering of Catalonia and the Sant Joan de Déu Barcelona Children’s Hospital have held a joint conference to strengthen collaboration in bioengineering and translational medicine. The event, held this morning at the IBEC, highlighted innovative projects, presented a joint PhD programme and encouraged the exchange of ideas between researchers from both institutions.